Steven Gannon - Net Worth and Insider Trading
Steven Gannon Net Worth
The estimated net worth of Steven Gannon is at least $1 Million dollars as of 2024-11-29. Steven Gannon is the Director of Fusion Pharmaceuticals Inc and owns about 56,400 shares of Fusion Pharmaceuticals Inc (FUSN) stock worth over $1 Million. Steven Gannon is also the Director of Xenon Pharmaceuticals Inc and owns about 2,000 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $86,300. Details can be seen in Steven Gannon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Gannon has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven Gannon
Steven Gannon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven Gannon owns 2 companies in total, including Fusion Pharmaceuticals Inc (FUSN) , and Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Steven Gannon’s form 4 insider trades.
Insider Ownership Summary of Steven Gannon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2022-08-11 | director |
| XENE | Xenon Pharmaceuticals Inc | 2024-03-07 | director |
Steven Gannon Latest Holdings Summary
Steven Gannon currently owns a total of 2 stocks. Among these stocks, Steven Gannon owns 56,400 shares of Fusion Pharmaceuticals Inc (FUSN) as of August 11, 2022, with a value of $1 Million and a weighting of 93.37%. Steven Gannon also owns 2,000 shares of Xenon Pharmaceuticals Inc (XENE) as of March 7, 2024, with a value of $86,300 and a weighting of 6.63%.
Latest Holdings of Steven Gannon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2022-08-11 | 56,400 | 21.55 | 1,215,420 |
| XENE | Xenon Pharmaceuticals Inc | 2024-03-07 | 2,000 | 43.15 | 86,300 |
Holding Weightings of Steven Gannon
Steven Gannon Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven Gannon has made a total of 4 transactions in Fusion Pharmaceuticals Inc (FUSN) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Fusion Pharmaceuticals Inc is the acquisition of 44,400 shares on August 11, 2022, which cost Steven Gannon around $90,132.
According to the SEC Form 4 filings, Steven Gannon has made a total of 1 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 13,000 shares on March 7, 2024, which brought Steven Gannon around $601,640.
Insider Trading History of Steven Gannon
- 1
Steven Gannon Trading Performance
GuruFocus tracks the stock performance after each of Steven Gannon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Gannon is -13.48%. GuruFocus also compares Steven Gannon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Gannon within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven Gannon's insider trading performs compared to the benchmark.
Performance of Steven Gannon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.68 | | | | | |
| Relative Return to S&P 500(%) | 14.97 | | | | | |
Steven Gannon Ownership Network
Steven Gannon Owned Company Details
What does Fusion Pharmaceuticals Inc do?
Who are the key executives at Fusion Pharmaceuticals Inc?
Steven Gannon is the director of Fusion Pharmaceuticals Inc. Other key executives at Fusion Pharmaceuticals Inc include Chief Medical Officer Dmitri Bobilev , director & Chief Executive Officer John Valliant , and Chief Scientific Officer Christopher P Leamon .
Fusion Pharmaceuticals Inc (FUSN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Fusion Pharmaceuticals Inc (FUSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusion Pharmaceuticals Inc (FUSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Fusion Pharmaceuticals Inc (FUSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fusion Pharmaceuticals Inc Insider Transactions
Steven Gannon Mailing Address
Above is the net worth, insider trading, and ownership report for Steven Gannon. You might contact Steven Gannon via mailing address: C/o Xenon Pharmaceuticals Inc., 200 - 3650 Gilmore Way, Burnaby A0 V5g 4w8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
